NIH-funded research R37 grant

Using human Schwann cell-derived exosomes to treat traumatic brain injury

Official title: Human Schwann Cell-Derived Exosome Treatment for Traumatic Brain Injury

Funded at University of Miami School of Medicine · NIH-10890128 · Data updated 2026-11-12

This study is looking at whether tiny particles called exosomes from human nerve cells can help people recover from traumatic brain injuries by reducing inflammation and improving brain health, and it’s for anyone who has experienced a TBI.

More Brain Injury research and trials

Quick facts

Grant typeR37 grant
Study typeNIH-funded research
Funding institutionUniversity of Miami School of Medicine
NIH-funded
Lab location1 site (Coral Gables, United States)
Project startAugust 1, 2023
Project endJuly 31, 2027
Funding year2024
Award (this year)$409,874
NIH project number5R37NS133195-02
Project IDNIH-10890128 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals who have experienced a traumatic brain injury and are seeking new treatment options.

Less likely to help

Patients with chronic or long-standing brain injuries that are not recent may not benefit from this research.

What this research studies

This research investigates the use of exosomes derived from human Schwann cells as a potential treatment for traumatic brain injury (TBI). The approach involves isolating and administering these exosomes intravenously to target various cellular and molecular mechanisms that contribute to brain injury and repair. The study aims to evaluate the optimal dosage and timing for treatment, assessing its effects on brain structure, biochemistry, and long-term behavioral outcomes. By focusing on anti-inflammatory properties, the research seeks to enhance recovery and improve the quality of life for individuals affected by TBI.

Why it matters

Potential benefit: If successful, this research could lead to a novel therapeutic option that significantly improves recovery outcomes for patients with traumatic brain injury.

How similar studies have gone: Other research has shown promise in using cell-derived exosomes for neurodegenerative conditions, suggesting potential success for this novel approach.

Where this research is happening

  • University of Miami School of Medicine
    Coral Gables, United States
    Active

Researchers

  • Principal investigator: Dietrich, W Dalton — University of Miami School of Medicine
  • Study coordinator: Dietrich, W Dalton

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.